BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janssen B, Vugts DJ, Funke U, Molenaar GT, Kruijer PS, van Berckel BN, Lammertsma AA, Windhorst AD. Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography. Biochim Biophys Acta 2016;1862:425-41. [PMID: 26643549 DOI: 10.1016/j.bbadis.2015.11.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Slifstein M, Abi-Dargham A. Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders. Semin Nucl Med 2017;47:54-63. [PMID: 27987558 DOI: 10.1053/j.semnuclmed.2016.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
2 Edison P, Donat CK, Sastre M. In vivo Imaging of Glial Activation in Alzheimer's Disease. Front Neurol 2018;9:625. [PMID: 30131755 DOI: 10.3389/fneur.2018.00625] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 11.8] [Reference Citation Analysis]
3 Chen Y, Cai Z, Ke Z. Antineuroinflammation of Minocycline in Stroke. Neurologist 2017;22:120-6. [PMID: 28644252 DOI: 10.1097/NRL.0000000000000136] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
4 Dadsetan S, Balzano T, Forteza J, Agusti A, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Gomez-Gimenez B, ElMlili N, Llansola M, Felipo V. Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. J Neuroinflammation 2016;13:245. [PMID: 27623772 DOI: 10.1186/s12974-016-0710-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
5 Haight ES, Forman TE, Cordonnier SA, James ML, Tawfik VL. Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back. Anesth Analg 2019;128:737-46. [PMID: 30883419 DOI: 10.1213/ANE.0000000000004033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
6 Zhao C, Jiang Z, Tian L, Tang L, Zhou A, Dong T. Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer's Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill. Dose Response 2022;20:15593258221115563. [PMID: 35898725 DOI: 10.1177/15593258221115563] [Reference Citation Analysis]
7 Tournier BB, Tsartsalis S, Rigaud D, Fossey C, Cailly T, Fabis F, Pham T, Grégoire M, Kövari E, Moulin-sallanon M, Savioz A, Millet P. TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer’s disease. Neurobiology of Disease 2019;121:95-105. [DOI: 10.1016/j.nbd.2018.09.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
8 Alam MM, Lee J, Lee SY. Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases. Nucl Med Mol Imaging 2017;51:283-96. [PMID: 29242722 DOI: 10.1007/s13139-017-0475-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
9 Dong S, Maniar S, Manole MD, Sun D. Cerebral Hypoperfusion and Other Shared Brain Pathologies in Ischemic Stroke and Alzheimer's Disease. Transl Stroke Res 2018;9:238-50. [PMID: 28971348 DOI: 10.1007/s12975-017-0570-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
10 Betlazar C, Middleton RJ, Banati RB, Liu GJ. The impact of high and low dose ionising radiation on the central nervous system. Redox Biol 2016;9:144-56. [PMID: 27544883 DOI: 10.1016/j.redox.2016.08.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
11 Gritti D, Delvecchio G, Ferro A, Bressi C, Brambilla P. Neuroinflammation in Major Depressive Disorder: A Review of PET Imaging Studies Examining the 18-kDa Translocator Protein. J Affect Disord 2021;292:642-51. [PMID: 34153835 DOI: 10.1016/j.jad.2021.06.001] [Reference Citation Analysis]
12 Moccia M, Ciccarelli O. Molecular and Metabolic Imaging in Multiple Sclerosis. Neuroimaging Clin N Am 2017;27:343-56. [PMID: 28391791 DOI: 10.1016/j.nic.2016.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
13 Heshmati-fakhr N, Sotoodehnejadnematalahi F, Yousefi N, Sayyah M, Hosseini SM, Pourbadie HG. Triggering microglia through toll-like receptor 2 pathway induced interferon β expression in cell and animal model of Alzheimer’s disease. NeuroReport 2018;29:1456-62. [DOI: 10.1097/wnr.0000000000001132] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Sokias R, Werry EL, Chua SW, Reekie TA, Munoz L, Wong ECN, Ittner LM, Kassiou M. Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination. Medchemcomm 2017;8:202-10. [PMID: 30108706 DOI: 10.1039/c6md00523c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fujita M, Tamano R, Yoneda S, Omachi S, Yogo E, Rokushima M, Shinohara S, Sakaguchi G, Hasegawa M, Asaki T. Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline. European Journal of Pharmacology 2018;833:263-74. [DOI: 10.1016/j.ejphar.2018.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Veronese M, Tuosto M, Marques TR, Howes O, Pascual B, Yu M, Masdeu JC, Turkheimer F, Bertoldo A, Zanotti-Fregonara P. Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function. Mol Imaging Biol 2021;23:560-71. [PMID: 33475944 DOI: 10.1007/s11307-020-01575-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Declercq LD, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G. Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT. Front Pharmacol 2016;7:88. [PMID: 27065872 DOI: 10.3389/fphar.2016.00088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
18 Tietz O, Marshall A, Bergman C, Wuest M, Wuest F. Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents. Nucl Med Biol 2018;62-63:9-17. [PMID: 29800798 DOI: 10.1016/j.nucmedbio.2018.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 MacAskill MG, Newby DE, Tavares AAS. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque. Cardiovasc Res 2019;115:1952-62. [PMID: 31233100 DOI: 10.1093/cvr/cvz162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:575-590. [PMID: 30406177 DOI: 10.1016/j.trci.2018.06.014] [Cited by in Crossref: 410] [Cited by in F6Publishing: 389] [Article Influence: 102.5] [Reference Citation Analysis]
21 Zinnhardt B, Wiesmann M, Honold L, Barca C, Schäfers M, Kiliaan AJ, Jacobs AH. In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. Theranostics 2018;8:2603-20. [PMID: 29774062 DOI: 10.7150/thno.24128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
22 Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 2018;23:323-34. [PMID: 28093569 DOI: 10.1038/mp.2016.248] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 25.2] [Reference Citation Analysis]
23 Metaxas A, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Finsen B. Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease. Alzheimers Res Ther 2019;11:38. [PMID: 31043179 DOI: 10.1186/s13195-019-0491-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
24 Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang MR, Aoki I, Suhara T, Higuchi M, Sahara N. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. J Alzheimers Dis 2018;61:1037-52. [PMID: 29332041 DOI: 10.3233/JAD-170509] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 9.3] [Reference Citation Analysis]
25 da Costa M, Bernardi J, Costa L, Fiuza T, Brandão R, Ribeiro MF, Amaral JD, Rodrigues CMP, Pereira ME. N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin. Chem Biol Interact 2017;272:37-46. [PMID: 28499986 DOI: 10.1016/j.cbi.2017.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
26 Martínez-Pinilla E, Rico AJ, Rivas-Santisteban R, Lillo J, Roda E, Navarro G, Lanciego JL, Franco R. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates. Brain Struct Funct 2020;225:2153-64. [PMID: 32691218 DOI: 10.1007/s00429-020-02116-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Fan Z, Dani M, Femminella GD, Wood M, Calsolaro V, Veronese M, Turkheimer F, Gentleman S, Brooks DJ, Hinz R, Edison P. Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. Eur J Nucl Med Mol Imaging 2018;45:1432-41. [PMID: 29523926 DOI: 10.1007/s00259-018-3984-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
28 Notter T, Meyer U. Letter to the Editor re: Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration. Mol Imaging Biol 2018;20:352-3. [PMID: 29427254 DOI: 10.1007/s11307-018-1172-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Guilarte TR. TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward. Pharmacol Ther 2019;194:44-58. [PMID: 30189290 DOI: 10.1016/j.pharmthera.2018.09.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 15.0] [Reference Citation Analysis]
30 McMillin M, Grant S, Frampton G, Andry S, Brown A, DeMorrow S. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation. 2016;13:198. [PMID: 27561705 DOI: 10.1186/s12974-016-0674-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
31 Sahara N, Maeda J, Ishikawa A, Tokunaga M, Suhara T, Higuchi M, Perry G, Avila J, Moreira P, Sorensen A, Tabaton M. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy. JAD 2018;64:S353-9. [DOI: 10.3233/jad-179933] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Donat CK, Mirzaei N, Tang S, Edison P, Sastre M. Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET. In: Perneczky R, editor. Biomarkers for Alzheimer’s Disease Drug Development. New York: Springer; 2018. pp. 323-39. [DOI: 10.1007/978-1-4939-7704-8_22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Freitas HR, Isaac AR, Malcher-Lopes R, Diaz BL, Trevenzoli IH, De Melo Reis RA. Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci 2018;21:695-714. [PMID: 28686542 DOI: 10.1080/1028415X.2017.1347373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
34 Navarro G, Borroto-Escuela D, Angelats E, Etayo Í, Reyes-Resina I, Pulido-Salgado M, Rodríguez-Pérez AI, Canela EI, Saura J, Lanciego JL, Labandeira-García JL, Saura CA, Fuxe K, Franco R. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain Behav Immun 2018;67:139-51. [PMID: 28843453 DOI: 10.1016/j.bbi.2017.08.015] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
35 Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry 2018;23:36-47. [PMID: 29203847 DOI: 10.1038/mp.2017.232] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 17.8] [Reference Citation Analysis]
36 Koga M, Nakagawa S, Kato A, Kusumi I. Caffeic acid reduces oxidative stress and microglial activation in the mouse hippocampus. Tissue and Cell 2019;60:14-20. [DOI: 10.1016/j.tice.2019.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
37 Chaney A, Williams SR, Boutin H. In vivo molecular imaging of neuroinflammation in Alzheimer's disease. J Neurochem 2019;149:438-51. [PMID: 30339715 DOI: 10.1111/jnc.14615] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
38 Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, Bun RS, Cacciola F, Cavedo E, Chiesa PA, Colliot O, Coman CM, Dubois B, Duggento A, Durrleman S, Ferretti MT, George N, Genthon R, Habert MO, Herholz K, Koronyo Y, Koronyo-Hamaoui M, Lamari F, Langevin T, Lehéricy S, Lorenceau J, Neri C, Nisticò R, Nyasse-Messene F, Ritchie C, Rossi S, Santarnecchi E, Sporns O, Verdooner SR, Vergallo A, Villain N, Younesi E, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI). Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. J Alzheimers Dis 2018;64:S47-S105. [PMID: 29562524 DOI: 10.3233/JAD-179932] [Cited by in Crossref: 69] [Cited by in F6Publishing: 34] [Article Influence: 23.0] [Reference Citation Analysis]
39 Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A. Rethinking on the concept of biomarkers in preclinical Alzheimer's disease. Neurol Sci 2016;37:663-72. [PMID: 26792010 DOI: 10.1007/s10072-016-2477-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
40 Kallinen A, Boyd R, Lane S, Bhalla R, Mardon K, Stimson DHR, Werry EL, Fulton R, Connor M, Kassiou M. Synthesis and in vitro evaluation of fluorine-18 benzimidazole sulfones as CB2 PET-radioligands. Org Biomol Chem 2019;17:5086-98. [PMID: 31070218 DOI: 10.1039/c9ob00656g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
41 Barichello T, Simões LR, Collodel A, Giridharan VV, Dal-pizzol F, Macedo D, Quevedo J. The translocator protein (18 kDa) and its role in neuropsychiatric disorders. Neuroscience & Biobehavioral Reviews 2017;83:183-99. [DOI: 10.1016/j.neubiorev.2017.10.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
42 Choi G. Importance of Microglial Cytoskeleton and the Actin-interacting Proteins in Alzheimer's Disease. BSL 2020;26:1-7. [DOI: 10.15616/bsl.2020.26.1.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Yousefi N, Sotoodehnejadnematalahi F, Heshmati-Fakhr N, Sayyah M, Hoseini M, Ghassemi S, Aliakbari S, Pourbadie HG. Prestimulation of Microglia Through TLR4 Pathway Promotes Interferon Beta Expression in a Rat Model of Alzheimer's Disease. J Mol Neurosci 2019;67:495-503. [PMID: 30610591 DOI: 10.1007/s12031-018-1249-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
44 Vries HED, Schwaninger M. Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:297-8. [DOI: 10.1016/j.bbadis.2015.12.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 2016;43:2219-27. [DOI: 10.1007/s00259-016-3457-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
46 Ji B, Ono M, Yamasaki T, Fujinaga M, Zhang MR, Seki C, Aoki I, Kito S, Sawada M, Suhara T, Sahara N, Higuchi M. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. J Cereb Blood Flow Metab 2021;41:2076-89. [PMID: 33557690 DOI: 10.1177/0271678X21992457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Tournier BB, Tsartsalis S, Ceyzériat K, Garibotto V, Millet P. In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease. Cells 2020;9:E1941. [PMID: 32839410 DOI: 10.3390/cells9091941] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
48 Cumming P, Burgher B, Patkar O, Breakspear M, Vasdev N, Thomas P, Liu GJ, Banati R. Sifting through the surfeit of neuroinflammation tracers. J Cereb Blood Flow Metab 2018;38:204-24. [PMID: 29256293 DOI: 10.1177/0271678X17748786] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 10.6] [Reference Citation Analysis]
49 Tournier BB, Tsartsalis S, Ceyzériat K, Fraser BH, Grégoire MC, Kövari E, Millet P. Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease. J Alzheimers Dis 2020;77:1043-56. [PMID: 32804124 DOI: 10.3233/JAD-200136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
50 Best L, Ghadery C, Pavese N, Tai YF, Strafella AP. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease. Curr Neurol Neurosci Rep 2019;19. [DOI: 10.1007/s11910-019-0934-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
51 Akwa Y. Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential. Int J Mol Sci 2020;21:E4812. [PMID: 32646017 DOI: 10.3390/ijms21134812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Zak A, Lemaire L, Chalon S, Chicheri G, Marzag H, Bodard S, Sérrière S, Routier S, Buron F, Vercouillie J. [18 F]-labeled positron emission tomography ligand for the histamine H4 receptor. J Labelled Comp Radiopharm 2021;64:363-72. [PMID: 34089268 DOI: 10.1002/jlcr.3929] [Reference Citation Analysis]